CSL (ASX:CSL) has reported net profit after tax of $1.729 billion for the twelve months ended 30 June 2018, an increase of 29 percent on the previous year, a result "slightly ahead" of the most recent guidance. …
Latest Video
New Stories
-
The consequences of R&D tax change not 'unintended'
November 21, 2018 - - Latest News -
Are new therapeutic groups an option?
November 21, 2018 - - Latest News -
More confirmed speakers for PharmaDispatch 2019
November 21, 2018 - - Latest News -
Pharmacy to 'evolve' in response to medicine complexity
November 21, 2018 - - Latest News -
ESCROW model most likely for SPA reform
November 20, 2018 - - Latest News -
What are these unpublished reviews?
November 20, 2018 - - Latest News -
NDIS tops 200,000 participants
November 20, 2018 - - Latest News